VolitionRX (NYSEAMERICAN:VNRX) is scheduled to be issuing its quarterly earnings data before the market opens on Tuesday, August 14th. Analysts expect the company to announce earnings of ($0.16) per share for the quarter.
VolitionRX (NYSEAMERICAN:VNRX) last released its quarterly earnings data on Thursday, May 10th. The medical research company reported ($0.17) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.16) by ($0.01).
VolitionRX opened at $1.69 on Friday, MarketBeat.com reports. VolitionRX has a 1 year low of $1.44 and a 1 year high of $4.00.
VolitionRX Limited, a life sciences company, engages in the development of blood tests to help diagnose a range of cancers worldwide. The company develops 39 epigenetic Nu.Q blood assays based on its Nucleosomics biomarker discovery platform. VolitionRX Limited is based in Singapore.
Featured Story: Growth Stocks, What They Are, What They Are Not
Receive News & Ratings for VolitionRX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VolitionRX and related companies with MarketBeat.com's FREE daily email newsletter.